VFMF
Vanguard U.S. Multifactor ETF·CBOE
--
--(--)
--
--(--)
Key Stats
Assets Under Management
497.84MUSD
Fund Flows (1Y)
109.58MUSD
Dividend Yield
1.49%
Discount/Premium to NAV
0.11%
Shares Outstanding
3.10M
Expense Ratio
0.18%
About Vanguard U.S. Multifactor ETF
Issuer
Vanguard
Brand
Vanguard
Inception Date
Feb 13, 2018
Structure
Open-Ended Fund
Index Tracked
--
Management Style
Active
Dividend Treatment
Distributes
Distribution Tax Treatment
Qualified dividends
Income Tax Type
Capital Gains
Max ST Capital Gains Rate
39.60%
Max LT Capital Gains Rate
20.00%
Primary Advisor
The Vanguard Group, Inc.
Distributor
Vanguard Marketing Corp.
VFMF belongs to Vanguard's suite of actively-managed factor-based funds. Rather than focusing solely on one factor, the fund evaluates US companies of all capitalization for their exposure to four factors: value, momentum, quality and low volatility. Value is measured by low security prices relative to fundamentals, momentum is measured by strong recent relative performance, and quality is measured by strong company fundamentals. Although VFMF is actively managed, a rules-based process is used to determine the fund's constituents. After removing the most volatile stocks, VFMF's advisor selects and weights securities, grouped by market cap, based on a ranking determined by combined value, momentum, and quality scores.
Classification
Asset Class
Equity
Category
Size and Style
Focus
Total Market
Niche
Broad-based
Strategy
Active
Geography
U.S.
Weighting Scheme
Proprietary
Selection Criteria
Proprietary
Analysis
Sector
Financial Services
27.00%
Healthcare
14.02%
Technology
13.89%
Consumer Cyclical
12.76%
Consumer Defensive
8.81%
Industrials
8.69%
Communication Services
7.29%
Energy
4.60%
Basic Materials
2.95%
Financial Services
27.00%
Healthcare
14.02%
Technology
13.89%
Consumer Cyclical
12.76%
Consumer Defensive
8.81%
Industrials
8.69%
Communication Services
7.29%
Energy
4.60%
Basic Materials
2.95%
Asset
Holdings
Symbol
Ratio
NEM
Newmont
1.12%
WFC
Wells Fargo
0.94%
HCA
HCA Healthcare
0.92%
ABBV
Abbvie
0.90%
GILD
Gilead Sciences
0.89%
MO
Altria Group
0.89%
Symbol
Ratio
LRCX
Lam Research
0.88%
BK
New York Mellon
0.88%
MU
Micron Technology
0.86%
AMGN
Amgen
0.83%
Top 10 Weight 9.11%
10 Total Holdings
See all holdings
Related Funds
Seasonals
Volume Profile
Trade Flow Insight
Community Forum
Loading...
Related News
No articles available
You can ask Aime
No Data
